Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy

The Journal of Clinical Investigation
Bijun ZengRanjeny Thomas

Abstract

Non-antigen-specific stimulatory cancer immunotherapies are commonly complicated by off-target effects. Antigen-specific immunotherapy, combining viral tumor antigen or personalized neoepitopes with immune targeting, offers a solution. However, the lack of flexible systems targeting tumor antigens to cross-presenting dendritic cells (DCs) limits clinical development. Although antigen-anti-Clec9A mAb conjugates target cross-presenting DCs, adjuvant must be codelivered for cytotoxic T lymphocyte (CTL) induction. We functionalized tailored nanoemulsions encapsulating tumor antigens to target Clec9A (Clec9A-TNE). Clec9A-TNE encapsulating OVA antigen targeted and activated cross-presenting DCs without additional adjuvant, promoting antigen-specific CD4+ and CD8+ T cell proliferation and CTL and antibody responses. OVA-Clec9A-TNE-induced DC activation required CD4 and CD8 epitopes, CD40, and IFN-α. Clec9A-TNE encapsulating HPV E6/E7 significantly suppressed HPV-associated tumor growth, while E6/E7-CpG did not. Clec9A-TNE loaded with pooled B16-F10 melanoma neoepitopes induced epitope-specific CD4+ and CD8+ T cell responses, permitting selection of immunogenic neoepitopes. Clec9A-TNE encapsulating 6 neoepitopes significantly suppresse...Continue Reading

References

Jul 7, 1997·The Journal of Experimental Medicine·S R BennettW R Heath
Dec 29, 2000·Nature·H HemmiS Akira
May 23, 2006·Nature Materials·Annette F DexterAnton P J Middelberg
Jul 26, 2006·The Journal of Experimental Medicine·Cristiana GuiducciFranck J Barrat
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gemma G KenterCornelis J M Melief
Apr 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anja SeubertAndreas Wack
May 24, 2008·The Journal of Clinical Investigation·David SanchoCaetano Reis e Sousa
Jul 26, 2008·Nature Nanotechnology·Wen JiangWarren C W Chan
Jan 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Juliana IdoyagaRalph M Steinman
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mireille H LahoudIrina Caminschi
Nov 6, 2009·The New England Journal of Medicine·Gemma G KenterCornelis J M Melief
May 19, 2010·The Journal of Experimental Medicine·Sarah L JongbloedKristen J Radford
Jun 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marij J P WeltersSjoerd H van der Burg
Jun 17, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mireille H LahoudIrina Caminschi
Sep 21, 2011·The Journal of Experimental Medicine·Mercedes B FuertesThomas F Gajewski
Oct 18, 2011·Nature·Nobuhiko KayagakiVishva M Dixit
Jan 3, 2012·Molecular Immunology·Irina CaminschiKen Shortman
Jul 13, 2013·Journal of the National Comprehensive Cancer Network : JNCCN·Dung T Le, Elizabeth M Jaffee
Jan 31, 2014·Science Translational Medicine·Leonel MaldonadoCornelia L Trimble
Apr 23, 2015·Nature·Sebastian KreiterUgur Sahin
Jun 16, 2015·Advances in Immunology·Elodie Segura, Sebastian Amigorena
Jul 23, 2015·Journal for Immunotherapy of Cancer·Angela D PardeeLisa H Butterfield

❮ Previous
Next ❯

Citations

Oct 4, 2019·European Journal of Immunology·Kazuya ToneGordon D Brown
Mar 18, 2020·Pharmaceutics·María Julia LambertiJessica Dal Col
Feb 28, 2019·Frontiers in Immunology·Jean-Charles CancelRaphaël Mattiuz
Mar 7, 2020·Drug Delivery and Translational Research·João Pedro MartinsHélder A Santos
Aug 18, 2018·Frontiers in Immunology·Matthias BrosStephan Grabbe
Jan 1, 2020·International Journal of Molecular Sciences·Yoshie KametaniYutaka Tokuda
May 6, 2019·Cancer Immunology Research·Pui Yeng LamStephen R Mattarollo
Jan 14, 2021·Nature Nanotechnology·Ningqiang GongMichael J Mitchell
Jul 1, 2020·Advanced Drug Delivery Reviews·Darrell J IrvineMurillo Silva
Dec 29, 2019·Seminars in Cancer Biology·Maria L GuevaraStefano Persano
Jan 29, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Janin ChandraMeihua Yu
Feb 16, 2021·Advanced Healthcare Materials·Faisal RazaQiu Mingfeng
Jan 8, 2021·Frontiers in Chemistry·Neelam ThakurParames C Sil
Jun 1, 2021·Frontiers in Immunology·Noémi Anna NagyEsther C de Jong
Aug 18, 2021·Advanced Drug Delivery Reviews·Tong YeWei Wei

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
FACS
confocal microscopy
FCS
flow cytometry
ELISA

Software Mentioned

DTS
GraphPad Prism

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.